Medicus Pharma (MDCX) Stock Chart & Stock Price History $1.97 -0.21 (-9.63%) As of 08/8/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Medicus Pharma Stock Price Performance The Medicus Pharma (MDCX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 18.93%. In the past month, the stock has decreased 40.30%, reflecting recent market activity. As of the latest close, Medicus Pharma traded at $1.97 with a market cap of $26.73 million and volume of 402,234 shares. Receive MDCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-18.26%1 Month Performance-40.30%3 Month Performance-57.08%Year-To-Date Performance-18.93% MDCX Stock Chart for Sunday, August, 10, 2025 MDCX Chart by TradingView Medicus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$2.18$1.97-9.63%$2.23$1.93402,234 shs$26.73 million08/07/2025$2.33$2.18-6.44%$2.41$2.06495,162 shs$29.59 million08/06/2025$2.41$2.33-3.32%$2.42$2.25229,593 shs$31.62 million08/05/2025$2.38$2.41+1.26%$2.50$2.31140,779 shs$32.70 million08/04/2025$2.57$2.38-7.39%$2.59$2.21374,452 shs$32.30 million08/01/2025$2.46$2.57+4.47%$2.65$2.41169,074 shs$34.88 million07/31/2025$2.50$2.46-1.60%$2.56$2.42248,726 shs$33.38 million07/30/2025$2.59$2.50-3.47%$2.67$2.41286,487 shs$33.93 million07/29/2025$2.44$2.59+6.15%$2.63$2.45327,401 shs$35.15 million07/28/2025$2.93$2.44-16.72%$2.94$2.38722,803 shs$33.11 million Get the Latest News and Ratings for MDCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$3.02$2.93-2.98%$3.06$2.92396,906 shs$39.76 million07/24/2025$3.05$3.02-0.98%$3.09$2.95277,856 shs$40.98 million07/23/2025$3.08$3.05-0.97%$3.12$2.97423,274 shs$41.40 million07/22/2025$3.06$3.08+0.65%$3.10$3.00204,144 shs$41.80 million07/21/2025$3.11$3.06-1.61%$3.13$3.00282,936 shs$41.52 million07/18/2025$3.25$3.11-4.31%$3.35$3.08395,110 shs$42.20 million07/17/2025$3.03$3.25+7.26%$3.25$3.02365,306 shs$44.10 million07/16/2025$2.97$3.03+2.02%$3.15$2.93382,012 shs$41.13 million07/15/2025$3.13$2.97-5.11%$3.11$2.94401,805 shs$40.30 million07/14/2025$3.03$3.13+3.30%$3.14$2.95479,666 shs$42.47 million07/11/2025$3.30$3.03-8.18%$3.25$2.98750,286 shs$41.12 million07/10/2025$3.31$3.30-0.30%$3.44$3.18693,703 shs$44.79 million07/09/2025$2.99$3.31+10.70%$3.59$3.202.06 million shs$44.92 million Related Companies Fate Therapeutics Stock Price Chart Immuneering Stock Price Chart Compugen Stock Price Chart Natural Alternatives International Stock Price Chart Protara Therapeutics Stock Price Chart Seres Therapeutics Stock Price Chart Spero Therapeutics Stock Price Chart Inhibikase Therapeutics Stock Price Chart BioHarvest Sciences Stock Price Chart Protalix BioTherapeutics Stock Price Chart Receive MDCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDCX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
